DYXC — DiaSys Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for DiaSys, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2003 June 30th | 2004 June 30th | 2005 June 30th | 2006 June 30th | 2007 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB/A | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.71 | 1.86 | 1.91 | 1.69 | 1.68 |
Cost of Revenue | |||||
Gross Profit | 1.63 | 1.05 | 0.933 | 0.937 | 0.89 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 4.34 | 4.39 | 3.84 | 2.69 | 2.4 |
Operating Profit | -1.63 | -2.53 | -1.93 | -1 | -0.718 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.62 | -2.97 | -2.03 | -1.04 | -0.774 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.62 | -2.99 | -2.03 | -1.05 | -0.785 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.62 | -2.99 | -2.03 | -1.05 | -0.785 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.62 | -2.99 | -2.03 | -1.05 | -0.785 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.149 | -0.234 | -0.12 | -0.053 | -0.035 |
Dividends per Share |